Results 211 to 220 of about 16,460 (261)

Use of hydrogen deuterium exchange mass spectrometry in tandem with modern structural biology. [PDF]

Biochem J
Nyvall HG, Shaw AL, Walsh EE, Bhatti H, Burke JE.   +4 more
europepmc   +1 more source

Identification and Nonclinical Characterization of SAR444200, a Novel Anti-GPC3 NANOBODY T-cell Engager, for the Treatment of GPC3+ Solid Tumors. [PDF]

Mol Cancer Ther
Meoni P, Vintém APB, Cortez-Retamozo VF, Jacobs J, De Tavernier E, Fiorentini P, Van Hoorick D, Batchelor JD, Svidritskiy E, Qiu Y, Dejonckheere E, Li A, Pao LI, Buyse MA.   +13 more
europepmc   +1 more source

Nanobody targeting glycan cap confers broad orthoebolavirus neutralization. [PDF]

Virol Sin
Zhang X, Liao Y, Liu X, Zhou J, Gao P, Dong X, Pan S, Duan H, Liu J, Chi X, Yang W.   +10 more
europepmc   +1 more source

Surface Plasmon Resonance (SPR) Workflow for Comparative Analysis of Nanobody Variants Binding to Lysozyme as a Model Ligand. [PDF]

Curr Protoc
Díaz-Galicia E, Gutu N, Peng Y, Valitova A, Renn D, Rueping M.   +5 more
europepmc   +1 more source

Exploring Trop-2-Nanobody PPI Interactions through Molecular Dynamics Simulations and Biovalidations. [PDF]

ACS Omega
Cheng J, Sun ZY, Guo Z, Hao Y, Hou G, Li Y, Wang Y, Feng Z, Xue Y, Meng L.   +9 more
europepmc   +1 more source

Tiny tools closing the gap: nanobodies in research and therapy. [PDF]

Function (Oxf)
Abdellatif M, Rajurkar J, Leonhardt H.
europepmc   +1 more source

Nanobody-Mediated c-MYC Degradation Inhibits Tumor Cell Progression. [PDF]

MedComm (2020)
Xue Y, Jiang H, Zong Z, Tian X, Miao Z, Li T, Wei Y, Deng H.   +7 more
europepmc   +1 more source

Proteolysis activity mapping and substrate discovery platform for identifying tumor-activated biosensors. [PDF]

Nat Chem Biol
Algov I, Van Heest A, Hopton M, Liang F, Holmes A, Hao L, Zhou X.   +6 more
europepmc   +1 more source

US28 nanobodies

, 2020
openaire   +1 more source